Nanophase Technologies Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kevin Cureton
- Full Time Employees
- 79
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- 1319 Marquette Drive Romeoville IL United States of America 60446
- IPO Date
- Nov 26, 1997
- CIK
- 0000883107
- Website
- nanophase.com
- Similar Companies
- Business
- Nanophase Technologies Corporation specializes in the development, manufacture, and commercialization of engineered nanomaterial products primarily focused on mineral-based health care solutions across beauty and life science categories. Its main products include surface-engineered zinc oxide and titanium dioxide used in sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care products marketed under the Solésence brand; advanced materials such as architectural and industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics materials, and various surface finishing technologies. The company serves diverse markets including personal care, cosmetics, medical diagnostics, coatings, catalysts, textiles, antimicrobials, and ultra-fine polishing applications, including in semiconductor wafers, hard disk drives, and specialty optics. Nanophase operates primarily in the United States, with manufacturing and research facilities in Romeoville and Burr Ridge, Illinois. Founded in 1989, the company is headquartered in Romeoville, Illinois. Recent major changes include Nanophase's strategic rebranding as Solésence Incorporated in 2025 to strengthen its presence in the skin care and beauty segments. The company has achieved record financial performance in 2024, with revenue increasing by 40% to $52.3 million and net income of $4.2 million reversing prior losses. Operational expansions include doubling production capacity and adding three new ISO 6 clean rooms with enhanced automation to support over $200 million in annual revenue potential. Nanophase launched over two dozen new SKUs in 2024 and continues to expand commercial manufacturing capabilities. It is actively pursuing uplisting to NASDAQ in 2025 and searching for a dedicated CFO to support this next growth phase. The Solésence subsidiary recorded a 171% year-over-year revenue increase in Q3 2024, underscoring strong demand for its mineral-based sunscreen technology with unique properties that avoid the white "ghosting" effect common in zinc oxide sunscreens. Nanophase Technologies integrates patented nanomaterial technologies with a solution-oriented approach to customer applications, leveraging 18 U.S. patents and 48 foreign patents. Its products combine nanotechnology innovation with compliance to FDA safety standards, positioning it as a leading provider of scientifically driven mineral-based health care and surface engineering solutions. The company targets both B2B customers including skin care manufacturers and industrial product users, and end markets in North America primarily. This comprehensive portfolio and strategic operational advancements underpin Nanophase’s robust growth trajectory and market positioning in the nanotechnology and personal care product sectors.
Solésence Announces Uplisting to Nasdaq
Nanophase Technologies Corp. (NANX) Q4 2024 Earnings Call Transcript
Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results
Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Solesence, Inc. f/k/a Nanophase Technologies Corporation (OTCQB: NANX) and Encourages Current NANX Shareholders to Contact the Firm
Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win
Solésence Launches New Investor Relations Website
Nanophase Technologies Rebrands as Solésence, Elevating the Future of Skin Health
Nanophase Technologies: Continued Evidence Of A Sunny Forecast
Nanophase Technologies Corporation (NANX) Q3 2024 Earnings Call Transcript
Nanophase Reports Record Third Quarter Revenue and Profit
Nanophase Technologies Announces Third Quarter 2024 Financial Release and Conference Call Details
Nanophase Technologies: Explosive Growth And Appreciation
Nanophase Technologies Corporation (NANX) Q2 2024 Earnings Call Transcript
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Nanophase Technologies Corporation (OTC: NANX)
Nanophase Reports Record Second Quarter Revenue and Profit
Nanophase Technologies Announces Second Quarter 2024 Financial Release and Conference Call Details
Solésence Beauty Science Wins Cosmopack North America Formulation Award for Third Year in a Row
Solésence Beauty Science and other Chicago Innovation Awards Winners to Ring the Nasdaq Opening Bell
Nanophase Reports Record First Quarter Results